Prime Minister Narendra Modi to visit Serum Institute of India on Saturday November 28 to take stock of Covishield vaccine. Serum Institute has partnered with global pharma giant AstraZeneca and the Oxford University for COVID vaccine.
“We have received a confirmation about PM Modi’s visit to the Serum Institute of India on Saturday, but his minute-to-minute program is yet to be received,” Pune Divisional Commissioner Saurabh Rao said.
The Central Drug Standard Control Organisation has granted permission to the makers of Covishield for pre-clinical test, examination and analysis. They have also given permission to seven other firms as well which includes medical giant like Gennova Biopharmaceuticals as well.
- Advertisement -
